Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dynamic air trapping during exercise in lymphangioleiomyomatosis and bronchodilator response
RBR-49sk2jPhase 3Completed
- Sponsor
- Instituto do Coração
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of salbutamol in lymphangioleiomyomatosis (LAM) (2 arms), sponsored by Instituto do Coração. Primary endpoint: Presence of dynamic hyperinflation during incremental cardiopulmonary exercise testing. Started Jan 2010; status: completed.
02
Drugs
salbutamol
03
Conditions
lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on RBR-49sk2j.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-49sk2j.